The week in health tech, explained in plain English.Get the free newsletter →
August 8, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Moderna Co-Founder Bets mRNA Cancer Vaccine Will Reshape Biotech

Kenneth Chien, a co-founder of Moderna who is no longer with the company, says its mRNA cancer vaccine could be transformative for biotechnology, according to a Q&A with STAT News. His comments place the spotlight on the question now driving the mRNA field: whether the platform that delivered Covid-19 vaccines can succeed against cancer.

Moderna's lead oncology candidate, developed with Merck, is a personalized therapeutic vaccine designed to train a patient's immune system to recognize tumor-specific mutations. It pairs with checkpoint inhibitors like Keytruda and has shown early promise in melanoma. Unlike a preventive shot, it is tailored to each patient's tumor, a manufacturing and logistics challenge as much as a scientific one.

Chien's optimism matters because Moderna faces falling Covid revenue and pressure to prove its pipeline can stand on its own. Success in oncology would validate mRNA as a durable therapeutic platform, not a pandemic-era one-off, and would shape investor expectations for the broader sector.

Sources

More in Health IT

Health IT

AI Aims to Prep Patients and Ease the Doctor Visit

Health systems are deploying AI to translate medical jargon and explain treatment options, aiming to make patient visits more informed and collaborative.

Why it matters: Better-prepared patients could reshape the doctor visit, but only if AI education is accurate and keeps clinicians in control.

Health IT

RAAPID Pitches One-Pass AI Coding to Cut Review Cycles

RAAPID's sponsored OnePass pitch claims audit-ready risk adjustment coding in one review cycle, reflecting a broader AI push to cut costly coding rework.

Why it matters: Coding accuracy drives risk adjustment payments, and tighter CMS audits make error-free, defensible coding a growing financial priority.

Health IT

Abridge, Kaiser Permanente Launch Care Signals AI Tool

Abridge and Kaiser Permanente launched Care Signals, extending ambient AI beyond visit documentation into the surrounding clinical and administrative work.

Why it matters: It marks ambient AI's shift from note-taking to automating the follow-up work that drives clinician burnout.